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Abstract
Vibrio cholerae is a Gram-negative bacterium known as a waterborne pathogen. It is often found
in marine conditions and can infect humans through ingestion. V. cholerae is responsible for
cholera, a disease characterized by profuse diarrhea, vomiting, and other dehydration symptoms.
Ultimately, severe cases can cause extreme electrolyte imbalances, shock, and acute renal failure
which lead to death in a short period of time. Annually, V. cholerae causes approximately 3
million cases of cholera and 100,000 deaths worldwide. V. cholerae can persist in motile and
biofilm lifestyles under aquatic and host conditions, a unique biphasic lifestyle that contributes to
Vibrio’s survival and pathogenicity. Previous research has shown that V. cholerae responds to
various fatty acids by altering behavior associated with virulence (biofilm formation, motility,
and antibiotic resistance). This study aimed to identify V. cholerae genes that participate in fatty
acid-mediated formation of biofilms, which are communities of bacteria formed for survival,
persistence, and pathogenicity. Using a transposon library, bioinformatically selected mutants
were evaluated for their ability to form biofilms in distinct physiological conditions with or
without three polyunsaturated fatty acids (PUFAs). The candidate mutants were subjected to 3
physiologically relevant PUFAs (alpha-linoleic acid [18:3ɑ], arachidonic acid [20:4], and
docosahexaenoic acid [22:6]). Each mutant’s growth characteristics and biofilm formation were
assessed under marine (30°C, pH 8.1, 600mM NaCl) and human host (37°C, pH 7.1, 150mM
NaCl) conditions. As indicated in preliminary research, temperature and salt induced changes in
biofilm formation and growth among the selected mutants. Interestingly, transposon mutant
VCA0785 displayed a decrease in biofilm production in marine and host conditions, indicating
an importance of this gene in biofilm formation. VC1348 produced biofilm mimicking wild-type
under marine conditions, but showed striking amounts of biofilm when PUFAs were available
under host conditions. Interestingly 18:3ɑ elicited almost 10 times the amount of biofilm in host
versus marine conditions. Under marine conditions, VC1710 displayed a stark decrease in
biofilm formation in the presence of each fatty acid, with 22:6 causing opposite effects between
conditions. Collectively, this study identified environment-specific alteration to fatty acidmediated biofilm formation, as well as implicating some potential methyl-accepting chemotaxis
proteins involved in signaling biofilm production in V. cholerae.
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Chapter 1: Introduction
1.1 Gram-Negative Membranes
Gram-negative bacteria can be differentiated microscopically from Gram-positive
bacteria by their inability to retain crystal violet (CV) following the staining procedure
developed by Hans Christian Gram.1 Whereas, Gram-positive bacteria are able to retain the CV
and thus appear purple under light microscopy after staining. This retention of CV is primarily
due to the thick peptidoglycan layer that is found on the outside of the single lipid bilayer

Figure 1.1 Structural model of a gram-negative cell envelope2
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membrane.3 As displayed in Figure 1.1, a thin layer of peptidoglycan can be found in the
periplasmic space in Gram-negative bacteria.
In Gram-negative bacteria the envelope, comprised of an inner membrane and outer
membrane, provides a platform for lipopolysaccharides (LPSs) and phospholipids (PLs), as well
as membrane proteins involved in processes such as transport, adhesion, cellular interaction, and
environmental sensing. Pertinent to this study are membrane proteins involved in the transport
and assimilation of exogenous fatty acids (FAs), as well as sensing proteins that modify bacterial
behavior by initiating signaling cascades depending on small molecules detected in the
environment.4 This study involves methyl-accepting chemotaxis proteins (MCPs), which have
been linked to critical involvement in cell regulation that impacts pathogenicity in bacteria.5, 7, 10
MCPs are located in the inner membrane in a gram-negative bacterium typically as part of twocomponent regulatory systems capable of recognizing small molecules and activating proteins
that will influence transcription of genes that will facilitate a response to the chemical stimuli.8
These proteins have been shown to mediate chemical detection that results in motility; however,
V. cholerae possesses an excess of homologues to MCPs, suggesting a wider range of behavioral
modification. The goal of this project is to determine whether MCPs participate in regulating
biofilm formation by responding to exogenous fatty acids. Previous studies have established the
membrane-associated machinery responsible for uptake and incorporation of fatty acids.7 It is
thought that as a bacterial cell takes up a fatty acid, or other materials that aid in virulence, a
metabolism pathway is engaged in allowing this molecule to reach the inner membrane and
MCPs, where a signaling cascade is triggered, leading to a change in gene regulation that could
change biofilm formation.8, 9 An increased diversity of fatty acids (ranging in carbon number and
level of unsaturation) have been used as candidates to demonstrate membrane phospholipid
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remodeling with various bacteria including V. cholerae. 7, 10, 11, 14 These studies discovered a
range of fatty acid-mediated effects on phenotypes associated with virulence, including motility
and biofilm formation. This study attempts to uncover genes involved in sensing fatty acids for
control of biofilm formation in V. cholerae.
1.2 Biofilms
Biofilms are clusters of bacteria anchored to a surface and held together by an
extracellular matrix, primarily composed of polymeric substances such as polysaccharides. 6, 7, 12,
14

Biofilm is considered an important factor in environmental survival for V. cholerae; as it is a

known phenotype related to bacterial persistence and survival in various environments.7, 14 In
addition to being problematic in medical settings (catheters, ventilators), biofilms are ubiquitous
in nature and can be found in industrial, aquatic, and other environmental water systems. Biofilm
forming microorganisms display a distinct genetic phenotype that allows for attachment, biofilm
cellular formation, and detachment unlike other microorganisms.12 V. cholerae is known to
create biofilms because it is often in turbid intertidal environments, where a capsular adaptation
is essential for survival and persistence for the bacteria.15 V. cholerae is prominent due to its
biphasic lifestyle; sessile and motile. This adaptability in lifestyle allows V. cholerae to take
advantage of multiple environments, like the mammalian intestines, which are nutrient rich, as
well as estuarine aquatic environment where more scarce nutrient sources such as copepods,
chironomids, cyanobacteria, fish and even water birds are available as reservoirs.16, 17
Transitioning through these phases allows V. cholerae the ability to maintain pathogenicity.
However, this is only accomplished because V. cholerae has various virulence factors to
withstand environmental stressors encountered such as: nutrient limitations, physical, chemical,
extreme temperature, bacteriophage predations, oxidative stress, and protozoan grazing in the
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marine environment.18, 19 In the human intestinal environment V. cholerae must overcome
additional stressors such as: iron limitations, bile acids, low pH, antimicrobial peptides, and
periods of nutrient deprivation.20 Under these various stressors V. cholerae can employ its sessile
lifestyle to allow attachment and formation of a biofilm as a means of survival.18, 19 V. cholerae’s
ability to survive in stressful environments is integral to its pathogenicity since it is hypervirulent
in the motile stage immediately after excretion from a human mammalian intestine (primarily
due to the abundance of nutrients it experiences in the host intestines), thus has the best chance at
furthering the infectious cycle.21

Figure 1.2 Diagram of biofilm formation in human intestines, displays motile and sessile life
phases of V. cholerae.15

While the specific signaling pathway involved in initiation of significant transcriptomic
changes resulting in biofilm formation is unknown, much has been identified about the pathways
involved in signaling cascades utilized once cells are in a biofilm matrix.15 Signaling cascades
that are utilized by the bacteria to regulate biofilm formation once it reaches the level of gene
4

activation include, the HapR regulator and VpsT or VpsR-dependent antirepression cascade.
HapR is a quorum sensing regulator that allows V. cholerae to enhance expression of a factor
involved in the stationary phase, V. cholerae also has FadL which all contribute to signaling that
allows V. cholerae to change and express different phenotypes such as motility and biofilm.15
This study attempts to investigate possible genes involved in the initiation of attachment as the
initial stage of biofilm formation, through the use of V. cholerae MCP transposon mutant library.
Many studies note the membrane remodeling V. cholerae is capable of and its
dependence on environmental conditions including the presence of fatty acids.7. 13, 14 This
remodeling has been linked to signaling pathways that are triggered based on the environment a
bacteria experiences.4, 15 V. cholerae is known, among other characteristics, for its substantial
amount of MCPs present in its genome, these have been cited as possibly involved in more
signaling systems than chemotaxis alone.13 Intriguingly, a study by Lambert et al. correlated
biofilm formation with several MCP genes, which further justified the current study. 29
1.3 Phospholipids and Fatty Acids
The PUFAs used in this study include linoleic acid (18:2), ɑ-linolenic acid (18:3ɑ),
arachidonic acid (20:4), and docosahexaenoic acid (22:6). These FAs are shown in Figures 1.3
through 1.5. The original plan was to use 18:2, 20:4, and 22:6 based on their relevance in V.
cholerae’s known environments. Additionally, these PUFAs are chemically diverse with regard
to carbon length and level of unsaturation. Initially the PUFAs 20:4 and 18:2 were chosen
because they are prevalent within the human host, with 18:2 being a major fatty acid in the
intestinal mucosa and 20:4 being a common cellular membrane fatty acid and signaling molecule
during inflammation. Both fatty acids are also commonly components of bile, which is secreted
into the small intestine to aid in digestion. 10, 12, 22 The PUFA 22:6, a component of fish oil and
5

was selected for its prevalence in aquatic environments, which V. cholerae is also known to live
in.15, 23 Furthermore, previous research has shown that 18:2, 20:4, and 22:6 are incorporated into
V. cholerae’s membrane when it is exposed to these long-chain PUFAs. However, due to
experimental error the vial containing 18:3ɑ was selected, in place of the 18:2 vial. Fatty acid
18:3ɑ has been seen in V. cholerae species after exposure to selected bile concentrations.24
The ability of bacteria, such as V. cholerae, to acquire fatty acids is essential to this study
because V. cholerae must process the necessary machinery to allow the PUFAs to reach the
MCPs on the inner membrane, which we posit are part of a signaling pathway that initiates
biofilm formation. Since MCPs are known to sense chemicals composed of double bonded
carbons, it would also be possible that they could also sense small molecular fatty acids, which
are made up of double bonded carbons much like the aforementioned chemical.

Figure 1.1 linoleic acid (18:2)
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Figure 1.2 ɑ-linolenic acid (18:3ɑ)

Figure 1.3 arachidonic acid (20:4)
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Figure 1.4 docosahexaenoic acid (22:6)

1.4 Previous Research
Previous research has shown various gram-negative bacterial species altering membrane
constitution and biofilm formation, as well as other virulence factors, in response to exogenous
FAs. The current treatment of cholera includes rehydration therapy, antibiotic treatment, and zinc
treatment (cases with minors).26 These treatment courses are effective for mild cases of cholera.
However with antibiotic resistance of V. cholerae on the rise there is a need for new treatment
options.7, 27 The diarrheal disease, cholera, is mainly contracted through contaminated water or
food that often has cholera bacteria in it from improper handling of fecal matter.26 Due to the
continued prevalence of V. cholerae, there have been many studies on prevention and treatment.
Biofilm production is known to be highly reliant on polysaccharides mainly
exopolysaccharides (EPS). EPSs are regulated and thus can be viewed as a selective quality of
biofilms in V. cholerae. Most researchers agree that the regulators of V. cholerae are
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transcriptional regulators, most commonly, quorum sensing regulators and two-component signal
transduction.28
By 2016, researchers identified the importance of fatty acids as more than carbon sources
that provide energy to bacterial cells. Fatty acids came to be seen as key nutrients influencing
virulence cascades.14 Previous research has significantly addressed the connections of fatty acids
and many other phenotypic qualities of V. cholerae. PUFAs, not synthesized de novo by V.
cholerae, could represent environment-specific signals for this pathogen which oscillates
between marine and host niches.29 Due to this, researchers have been investigating the impact of
fatty acids on biofilm formation and other phenotypes associated with virulence and survival.
Biofilms are a phenotype shared among bacteria. They provide a method for survival and
transmission of bacteria in diverse environments, because biofilms are an enclosed matrix that
forms a surface community. As one article states, biofilm formation is the preferred mode of
growth because it provides enhanced growth & survival due to protection from antimicrobial
compounds and access to nutrients.28 An interesting feature of V. cholerae is that it encodes a
significantly larger number of methyl-accepting chemotaxis proteins (MCPs) than other related
bacteria.30, 31 V. Cholerae is also primarily found in environments, both aquatic and host, that
have a high diversity of fatty acids, some have posited that the abundance of MCPs could be
attributed to their role in control of biofilm formation. 11, 32 Lambert et al’s study provides a
compiled list of genes to begin testing in my research due to the inclusion of indicated gene
expression (up-regulation and down-regulation).30
1.5 Vibrio cholerae
Vibrio cholerae is a gram-negative bacterium discovered in 1871 when the first pandemic
was recorded in India.33 V. cholerae is known to cause infection in human hosts, which is called
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cholera. This disease is characterized by vomiting, diarrhea, dehydration, electrolyte imbalances,
and acute renal failure. In severe cases this can lead to death in a relatively short period of time.26
Fish can also be infected by this disease and act as carriers to the human host. According to the
CDC cholera is commonly contracted via shellfish and contaminated water. 13, 28
V. cholerae has a very high infectious dose and is hyper infectious upon exiting its host.
V. cholerae is a flagellated bacterium that inhabits the lower intestines. Despite low tolerance to
acidity of the stomach, the bacteria possesses a virulence cascade that is initiated upon entry into
the small intestine.7, 13, 14 The ensuing pathogenesis allows V. cholerae to colonize the intestinal
epithelial cell layer and ultimately express cholera toxin, the key virulence factor that causes
cellular water loss and diarrhea, the main symptom of cholera.14 The biphasic lifestyle is unique
to V. cholerae and allows this bacterium to live in both marine and host conditions. V. cholerae
also has the ability to produce a biofilm when under stress. Some literature indicates that various
fatty acids could be linked to sensing and signaling proteins in V. cholerae.30 The initiation of
attachment for the formation of biofilm is thought to be linked to MCPs sensing fatty acids once
inside the outer membrane.11, 14
Currently, treatment for V. cholerae includes rehydration therapy, antibiotics protocols,
and zinc treatments.33 However since this bacterium is more virulent after growth in a host it is
important to note sanitation must be taken into account for disease control. Additionally,
antibiotic resistance is on the rise.7, 28, 36 Thus, this project sought to, collectively, focus on i) the
identification of genes likely to participate in fatty acid-mediated biofilm formation using
previous literature and bioinformatics and ii) utilizing the V. cholerae nonredundant transposon
library to test candidate genes for their potential roles in fatty acid control of biofilm formation,
in the aim to identify possible genes indicated in the regulation of biofilm formation in V.
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cholerae.36 Identification of genes involved in mediated biofilm formation would contribute to
our understanding of environmental sensing in V. cholerae. Central to the hypothesis of this
project is that some of the MCPs may be involved in sensing and responding to exogenous fatty
acids. To simulate V. cholerae’s biphasic environments, where fatty acids can be found, this
study used two designed environmental conditions, marine and host. Our study aimed to
identify possible genes involved in Vibrio cholerae biofilm formation influenced by
physiological fatty acids ([18:3ɑ], [20:4], & [22:6]) as a way of targeting biofilm regulation
in V. cholerae.
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Chapter 2: Materials and Methods
2.1 Growth Procedure and Inocula Preparation
Vibrio cholerae O1 El Tor C6706 was the wild-type strain used in this study. The
transposon mutants were acquired by duplicating the transposon library previously published.34
The bacterial cultures used in this study were routinely maintained in Luria broth and agar
media. Overnight cultures were incubated shaking for approximately 16 hours in Luria broth. For
many experiments, cultures were pelleted, washed, and resuspended in M9 minimal media
supplemented with 0.4% casamino acids (0.2% glucose, 2mM MgSO4, 0.1mM CaCl2). Bacterial
inocula was prepared at an OD600 of 0.1 for biofilm experiments. The V. cholerae cultures used
in growth curve analysis were grown in CM9 minimal medium incubated at 37℃ for 24 hours
with inocula starting at OD600 of 0.05, with readings taken every hour.32
2.2 Media preparation
The initial screening tests were conducted using CM9 media, however after evaluation,
based on observed pH changes the media was converted to CM9 minimal media buffered with
HEPES (0.1M) at 7.1pH (host) or 8.1pH (marine) and 150mM NaCl concentration (host) or
600mM NaCl concentration (marine). HEPES was prepared using a HEPES stock concentration
of 0.25M. The desired pH was obtained through addition of sodium hydroxide pellets while
monitoring pH. After this procedural change, all mutants were tested using the HEPES media
and CM9 was discontinued.
Each fatty acid was prepared using 1ml of media such that the final concentration would
be 300uM in each well containing 200ul. In a biosafety hood the inocula and FAs were pipetted
into a 96 well microtiter plate; the fatty acid solutions were added to their respective wells in 30
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microliters per well and the incocula were added in 170 microliters per each well using a
multipipettor.37
2.3 Growth Curve Analysis
A traditional growth curve was conducted on initial V. cholerae transposon mutants to
establish growth characteristics and a baseline for comparison in bioassay growth analysis. At
one-hour intervals over the course of 10 hours, each culture was assessed for growth
spectrophotometrically at an absorbance of 600nm. The cultures of V. cholerae were grown in
CM9 minimal media without fatty acids at 37℃ for 12 hours. Each culture was inoculated at a
starting OD600 of 0.05 and growth was assessed by measuring the absorbance (OD600) of the
cultures once every hour for 10 hours.
2.4 Biofilm Formation Assay Procedure and Incubation
To assess the effects of FAs 18:2, 18:3ɑ, 20:4, and 22:6 on biofilm formation in V.
cholerae, transposon mutant cultures were exposed to two main environmental designs, marine
and physiological, to gauge response in biofilm formation assays. Both conditions held
incubation time at 24 hours static incubation, as the indicated standard via various studies, and
utilized CM9 and HEPES minimal media as the base nutrient source.4, 38, 39 Additionally, both
conditions had a control consisting of wild type V. cholerae (C6706) and no fatty acid. Each
assay also included the 7 other V. cholerae mutants being tested and three FAs in triplicate form.
These assays were then examined using crystal violet staining methods to measure biofilm
growth.36 The physiological design consisted of the above experimental procedure and main
conditions with the distinction of supplementing 150mM NaCl and incubating at 37℃, while the
marine design had 600mM NaCl and 30℃ incubation temperature. All incubations were
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performed under static conditions in an incubator with a humid environment (water trays beneath
microtiter plates).
2.5 Spectrophotometric Quantification
Spectrophotometry uses absorbances to measure the amount of a substance by measuring
the number of photons absorbed after the selected light wavelength passes through the substance.
In this project UV-Vis at 590nm is used to quantify the amount of biofilm formed. The
absorbance of crystal violet indicates the amount of biofilm formed per microtiter well, which is
measured by staining the polysaccharides that make up the biofilm, and then resuspending them
in acetic acid.41 A Biotek Synergy 2 instrument was used for all the readings and produced an
excel document containing the absorbance values per well.
The microtiter plate is then processed and read after the 24-hour incubation. By using the
established technique for staining biofilms, the microtiter plate is first dumped and then gently
washed by submersion in deionized water 4-5 times. Then 0.01% crystal violet (CV) solution is
multipipetted into each well in 225 microliter amounts. The plate then sits for 15 minutes with
the CV. After the 15 minutes the plate is submerged in 4-5 more washes of deionized water until
the water is clear. The plate was then placed upside down to air dry for a minimum of 30
minutes. At the conclusion of this drying time each well received 225 microliters of acetic acid,
which then sat in the wells for 15 minutes. After the 15 minutes, the contents of each well were
transferred to a new labeled plate, to avoid coloration interference. The plates were then scanned
in a mass spectrometer to assess the amount of biofilm formation in the solution.
The data gathered from the biofilm processing was compiled into excel documents and then
analyzed. Two biological replicates were obtained for each assay, and each experiment was
performed in triplicate. The data was transferred to Excel for generation of graphs and
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calculation of averages and standard deviations. All results in this study were interpreted based
on biofilm response of the wild-type control; therefore, evaluation is described by relative
differences as opposed to calculations of statistical significance. Measures of significance are
based on the degree of change observed in the mutant when compared to the experiment control
(C6706 and no PUFA exposure), indicating notable findings -- not statistical significance due to
the extensive amount of variables.
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Chapter 3: Results
3.1 Introduction
This project sought to identify deviations from wild-type trends in biofilm formation
among 30 V. cholerae transposon mutants when exposed to PUFAs under marine and host
conditions. The initial steps of this project included screenings of 14 indicated mutants and
development of two separate assay conditions to analyze V. cholerae’s biphasic lifestyle in
biofilm formation. After identifying particular trends further testing was conducted; expanding
the screening to over 30 MCPs available in the aforementioned transposon library.
Unfortunately, due to restrictions from the COVID-19 pandemic screening was unable to be
completed.
3.2 Growth Curve Results
Figure 3.1 shows the growth curve performed on transposon mutants selected from the
initial grouping of test mutants. This growth curve was conducted in CM9 minimal media using
cultures that had been grown overnight at 37℃ in CM9 media with a starting OD600 of 0.05.
Absorbance measures were taken every hour for ten hours. These results show that two
transposon mutants (VCA0658 and VCA0785) had significantly higher growth when compared
to the wildtype mutant (C6706) and the other mutants. This is thought to indicate that VCA0658
and VCA0785 are more planktonic growers, thus VCA0658 and VCA0785 are both
characterized as low biofilm producers. This confirms the results of the assays despite the
presence of a true blank.
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Figure 3.1 Growth curve results including wildtype and 7 transposon mutants of V. cholerae
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3.3 Initial Screening Bioassay Samples
Biofilm formation in V. cholerae in the presence or absence of one of the three PUFAs
was tested, all in 300µM amounts, using the established. These biofilms were stained and
measured according to the above procedure. Figure 3.2 shows biofilm formation of Group B
transposon mutants in initial testing conditions. This bioassay shows six transposon V. cholerae
mutants that display a trend with no notable deviations from the control sample, thus eliminating
them from further study.

Figure 3.2 Biofilm formation of V. cholerae in the presence of alpha-linoleic acid, arachidonic
acid, and docosahexaenoic acid with CM9 media incubated at 37℃ for 24 hours. No notable
deviation from control (C6706).
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3.4 Marine Condition Bioassay Samples
As previously mentioned, biofilm formation in V. cholerae in the presence or absence of
one of the three PUFAs was tested, all in 300µM amounts, using the established procedure
explained in Chapter 2 of this work. These biofilms were stained and measured according to the
above procedure. Figure 3.3 shows biofilm formation results for Group D mutants, see table 1.1
in supplemental material. Interesting findings include the upregulation in the presence of all three
PUFAs (particularly 20:4 and 22:6) that is observed in VC1348. VC1710 and VCA0785 mutants
show no biofilm production in the presence of the three PUFAs, this could indicate that these
mutants are vital in biofilm formation when exposed to marine conditions.

Figure 3.3 Biofilm formation of V. cholerae transposon mutants Group D in the presence of
alpha-linolenic acid, arachidonic acid, and docosahexaenoic acid with HEPES pH 8.1 NaCl
600mM incubated at 30℃.
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Figure 3.4 displays identical testing conditions as used in the bioassay for Figure 3.3 with
the exception of the transposon mutant group, which is now Group E according to Table 1.1 in
the supplemental material section. These biofilm formation results show an increase in biofilm
formation in the presence of PUFAs 20:4 and 22:6 compared to the control sample, excluding
VC1898 where biofilm production in presence of 20:4 is not greater than control. In VC1405 and
VC1403 biofilm formation is decreased compared to control in the presence of PUFA 18:3ɑ.

Figure 3.4 Biofilm formation of V. cholerae transposon mutants Group E in the presence of
alpha-linolenic acid, arachidonic acid, and docosahexaenoic acid with HEPES pH 8.1 NaCl
600mM incubated at 30℃.
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Figure 3.5 also uses identical testing conditions as both assays in Figure 3.3 and Figure
3.4, but with V. cholerae transposon mutants Group F according to Table 1.1. Figure 3.5 results
display notable increases in biofilm production in the presence of 20:4 and 22:6 in VC2439,
VC1967, VCA0068, VCA0176, VCA0663, VCA0008. In all mutants, excluding VC2439 and
VC1967, biofilm formation was decreased in the presence of 18:3ɑ, this suggests these mutants
are important for biofilm formation under marine conditions.

Figure 3.5 Biofilm formation of V. cholerae transposon mutants Group F in the presence of
alpha-linolenic acid, arachidonic acid, and docosahexaenoic acid with HEPES pH 8.1 NaCl
600mM incubated at 30℃.
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3.5 Host Condition Bioassay Samples
Biofilm production in V. cholerae transposon mutants in the presence of the three
selected PUFAs was also tested under host conditions to accommodate V. cholerae’s biphasic
lifestyle and provide comparative data. Figure 3.6 displays biofilm production in Group D
mutants, similar to Figure 3.3. This data displays an interesting increase in biofilm formation in
the presence of PUFA 22:6 for mutant VC1348 and a decrease in all the other mutants when
compared to the control sample. This suggests these mutants could be regulators of biofilm
production under host conditions when exposed to FA 22:6. Interestingly, VCA0785 shows a
decrease in biofilm production in all exposures when compared to the control sample, this
indicates VCA0785 is an important gene in biofilm formation under host conditions.

Figure 3.6 Biofilm formation of V. cholerae Group D transposon mutants, in the presence of
alpha-linolenic acid, arachidonic acid, and docosahexaenoic acid with HEPES pH7.1 NaCl
150mM incubated at 37℃.
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Figure 3.7 displays Group F mutants, similar to Figure 3.5, except Figure 3.7 shows the
results from host conditions. This data shows all of the mutants, excluding VCA0176 and
VCA0268, behave as the control sample in biofilm formation. VCA0176 shows similar amounts
of biofilm production in the presence of 18:2 and 20:4 as observed in no fatty acid. VCA0268
shows abnormal trends when considering no fatty acid and 18:2 in comparison to the control
sample. All mutants in Figure 3.7 show decreased biofilm production in all PUFAs conditions
when compared to the control sample (C6706).

Figure 3.7 Biofilm formation of V. cholerae Group F transposon mutants, in the presence of
alpha-linolenic acid, arachidonic acid, and docosahexaenoic acid with HEPES pH7.1 NaCl
150mM incubated at 37℃.
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Chapter 4: Discussion
4.1 Discussion
V. cholerae is a gram-negative pathogen in humans that exhibits a biphasic lifestyle. This
pathogen is responsible for cholerae infections worldwide every year. Antibiotics are the main
course of treatment for, what in some cases is a life threatening disease.13, 14, 25, 26 One of V.
cholerae’s main virulence factors that allows it to be infectious is its ability to form a biofilm and
resist antibiotic treatment.27 Recently, researchers have seen an increase in antibiotic resistance
in V. cholerae, thus novel treatments are being sought out. Once FAs reach the inner membrane
MCPs have been known to transport them into the cell, which is thought to initiate signaling
cascades that alter the bacterium’s virulence genes.42 Previous research on V. cholerae explored
MCPs involvement in other physiological traits such as motility, membrane altering, and
different genes involved in biofilm signaling pathways.13, 14, 30 Additional research has shown
gram-negative bacteria have the ability to sense PUFAs in their environment and alter their own
membrane accordingly.14 The purpose of this study was to examine the involvement of PUFAs
in mediating biofilm formation via MCPs in various V. cholerae transposon mutants under
conditions the bacteria would normally experience, such as marine and host.
The initial stages of this project focused on the screening of 14 V. cholerae transposon
mutants indicated in biofilm formation signaling pathways, allowing confirmation of transposon
mutants that displayed trends that diverged from the control sample during testing.31, 36 This was
done by assessing a representative sample of mutant growth characteristics and biofilm
formation in the presence of CM9 media, to compare with the bioassays, using 3 physiologically
relevant fatty acids (linoleic acid [18:2], arachidonic acid [20:4], and docosahexaenoic acid
[22:6]). Biofilm formation of the wild-type strain (C6706) of V. cholerae in CM9 was
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interestingly decreased in the presence of 18:2 and increased in the presence of 20:4 and 22:6.
While growth patterns among the mutants remained similar, there were notable differences in
capacity for biofilm formation using a microtiter plate-based crystal violet assay. Six of the
tested mutants exhibited the wild-type pattern of biofilm formation as shown in Figure 3.2,
suggesting that their respective gene products are not involved in the phenotype. There were no
largely notable changes observed in the presence of 18:3ɑ, suggesting further study would be
needed to discover differences in biofilm production that are significant.
Ultimately, we found multiple mutant genes that indicate MCPs could participate in
biofilm formation since these sensing molecules altered the V. cholerae’s ability to form biofilms
under experimental conditions. Interestingly mutant VCA0785 lacks a functional methylaccepting chemotaxis protein, but responds to all three fatty acids. VCA0785 displayed a
decrease in biofilm production in the presence of all three PUFAs (18:3ɑ, 20:4, 22:6); suggesting
that V. cholerae might rely on this gene under both marine and host conditions. This result is
unique because this gene is characterized by its GGDEF family protein, which is a signaling
protein. This could mean that MCPs are involved supporting the hypothesis of MCP involvement
in mediating biofilm formation. Future studies should explore the involvement of this gene in
biofilm production for V. cholerae to further discover the mechanisms.
In comparison, VC1348 displayed an increase in biofilm production in the presence of all
three tested PUFAs (18:3ɑ, 20:4, 22:6): indicating that V. cholerae relies on this gene in both
conditions for regulation of biofilm production. VC1348 has been identified as a response
regulator through bioinformatics and thus should be considered more closely. Additionally,
VC1710 displayed unharmonious biofilm production between the two conditions; showing an
increase in biofilm production in the host conditions in the presence of PUFA 18:3ɑ, and a
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decrease in biofilm production under marine conditions in the presence of all tested PUFAs. This
gene was chosen because it contains an EAL domain and is thus involved in diverse signaling.
The above results suggest there could be complex signaling pathways at play, however further
study is needed.
While initial testing in CM9 media provided proof of alterations in selected mutants
under testing conditions, further testing was conducted to differentiate effects of temperature,
pH, and salt concentration. Temperature changes were first examined remaining in CM9 minimal
media, continuing use of 37℃ and adding 30℃ testing conditions, while performing the
previously established experiment protocol.
Although initial testing did not show significant changes in media pH from the start of a
bioassay compared to the end in CM9, a change in media to HEPES buffered CM9 was made to
better control pH. HEPES is a pH buffered media and is better able to hold specific salt
concentrations. As suspected, the results demonstrate different responses for biofilm formation
between the two environmental conditions. This study found marine conditions elicit
significantly higher biofilm production in the absence of fatty acids; while 22:6 yielded higher
biofilm amounts in human conditions, 20:4 generated the most biofilm under marine conditions.
This unique interaction could be due to various reasons since there are a large number of
variables. Interestingly, some mutants exhibited divergent biofilm behavior; specifically, the
VCA0658 (known for aerotaxis) mutant was only able to form biofilm in human conditions
when 22:6 was supplemented. Collectively, we have identified intra- and inter-conditional
dependencies among V. cholerae wild-type and MCP mutants that furthered our understanding
of fatty acid-mediated biofilm formation for future work.
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Possible sources of interference should be noted, as they cause significant deviation
between experiments and thus limit the conclusiveness of the provided data. One interference
source is the variance outside temperature, as every experiment was transported for a short
period of time outdoors throughout various seasons and temperatures within the first minutes of
exposure in the microtiter plate. While sterility was maintained, the effects of this short-term
exposure on the bioassay are uncontrolled for and thus should be considered. This decision was
due to testing facility necessity, and onsite construction. Furthermore, biofilm controls were
included by staining control wells for biofilm production and quantified; they showed negligible
absorbances (0.03).
4.2 Future Research
Future work to be carried out on this project includes completing the screening of MCPs
using the available resources to test the MCP transposon mutants that were not tested due to the
COVID-19 pandemic. Additionally, due to clerical error this study used alpha-linolenic acid
thus, future studies should consider the use of fatty acid (linoleic acid [18:2]) since it is more
prevalent in the human body, where V. cholerae can live. This study did not quantify the amount
of fatty acid, of the 300µM concentration free fatty acid, consumed by the mutants during
incubation. Future studies should consider the amount of fatty acid utilized by V. cholerae
transposon mutants during a bioassay, which could be accomplished by conducting a titration to
gauge sensitivity and assess physiologically relevant concentrations. A bioassay blank should
also be included in future studies to provide a more concrete baseline measurement when
determining absorbance for biofilm quantification. It would also be beneficial for future studies
to conduct genetic complementation to confidently determine the transposon mutant effects.
Finally, future work should examine the genomic characteristics hindered by the transposon
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mutants to evaluate what signaling pathways might be involved in biofilm formation for V.
cholerae.
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Supplemental Materials
Table 1.1 V. cholerae Transposon Mutant Grouping Key Independent of Media Type
Group A
VC1298
VC1413
VC1859
VC2161
VCA0658
VCA0773
VCA0854

Group B
VC1081
VC1085
VC1315
VC1348
VC1349
VC1710
VCA0785

Group D
VC1081
VC1085
VC1348
VC1349
VC1413
VC1710
VCA0785

Group C
VC1081
VC1298
VC1859
VC2161
VCA0658
VCA0773
VCA0785

Group E
VC1394
VC1403
VC1405
VC1535
VC1643
VC1868
VC1898

Group F
VC1967
VC2439
VCA0008
VCA0068
VCA0176
VCA0268
VCA0663

Group G
VC1081
VC1085
VC1348
VC1349
VC1413
VC1710
VCA0785
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